National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

doxorubicin hydrochloride liposome (DOK-soh-ROO-bih-sin HY-droh-KLOR-ide LY-poh-SOME)

 A form of the anticancer drug doxorubicin that is contained in very tiny, fat-like particles. It may have fewer side effects and work better than doxorubicin. Doxorubicin hydrochloride liposome is used to treat ovarian cancer, AIDS-related Kaposi sarcoma, and multiple myeloma in patients whose disease has not gotten better after treatment with other anticancer drugs. It may be used together with other anticancer drugs. It is also being studied in the treatment of other types of cancer. Doxorubicin hydrochloride liposome is a type of anthracycline antitumor antibiotic. Also called Dox-SL, Doxil, Evacet, and LipoDox.



Previous Definitions:doxazosin mesylate, doxercalciferol, Doxil, doxorubicin, doxorubicin hydrochloride
Next Definitions:doxycycline, DPA, DPPE, DR4, DR5

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov